NOD1 and type 2 diabetes mellitus: In T2DM patients, NOD1 and NOD2 expression is increased in CD14+ monocytes, and correlates with disease progression, TNF-α and IL-6 serum levels and the abundance of pro-inflammatory markers such as CD11b and CD36 on monocytes [97].